| Primary |
| Non-hodgkin's Lymphoma |
14.6% |
| Hodgkin's Disease |
14.2% |
| Acute Lymphocytic Leukaemia |
10.7% |
| Chemotherapy |
6.9% |
| Drug Use For Unknown Indication |
5.2% |
| Prophylaxis Of Nausea And Vomiting |
5.2% |
| Testis Cancer |
5.2% |
| General Anaesthesia |
4.3% |
| Preoperative Care |
4.3% |
| B-cell Lymphoma |
3.4% |
| Multiple Myeloma |
3.4% |
| Neuromuscular Blocking Therapy |
3.4% |
| Acute Lymphocytic Leukaemia Recurrent |
3.0% |
| Meningitis Cryptococcal |
3.0% |
| Prophylaxis |
3.0% |
| Headache |
2.6% |
| Osteotomy |
2.6% |
| Local Anaesthesia |
1.7% |
| Pain |
1.7% |
| Vomiting |
1.7% |
|
| Infection |
11.1% |
| Osteonecrosis |
11.1% |
| Grand Mal Convulsion |
8.9% |
| Febrile Neutropenia |
6.7% |
| Sepsis |
6.7% |
| Vomiting |
6.7% |
| Diverticulitis |
4.4% |
| Reversible Posterior Leukoencephalopathy Syndrome |
4.4% |
| Sinus Tachycardia |
4.4% |
| Toxic Epidermal Necrolysis |
4.4% |
| Tri-iodothyronine Decreased |
4.4% |
| Tumour Lysis Syndrome |
4.4% |
| Tympanic Membrane Perforation |
4.4% |
| Urinary Retention |
4.4% |
| Blood Glucose Increased |
2.2% |
| Bone Marrow Failure |
2.2% |
| Drug Ineffective |
2.2% |
| Liver Function Test Abnormal |
2.2% |
| Maternal Drugs Affecting Foetus |
2.2% |
| Myositis |
2.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
23.9% |
| Multiple Myeloma |
19.1% |
| Acute Lymphocytic Leukaemia |
8.4% |
| Mantle Cell Lymphoma |
6.5% |
| T-cell Lymphoma |
5.2% |
| Testis Cancer |
4.7% |
| Chemotherapy |
4.2% |
| Hodgkin's Disease |
3.2% |
| Diffuse Large B-cell Lymphoma |
3.0% |
| Prophylaxis |
2.9% |
| Prophylaxis Of Nausea And Vomiting |
2.6% |
| Non-hodgkin's Lymphoma |
2.2% |
| Breast Cancer |
2.1% |
| Nausea |
2.1% |
| Hypertension |
2.0% |
| Amyloidosis |
1.7% |
| T-cell Type Acute Leukaemia |
1.7% |
| Premedication |
1.6% |
| Hiv Infection |
1.5% |
| Peripheral T-cell Lymphoma Unspecified |
1.5% |
|
| Osteonecrosis |
13.5% |
| Vomiting |
13.5% |
| Thrombocytopenia |
7.5% |
| Pyrexia |
6.8% |
| Neutropenia |
5.3% |
| Staphylococcal Infection |
5.3% |
| Hepatitis |
4.5% |
| Hyperglycaemia |
4.5% |
| Renal Failure |
3.8% |
| Respiratory Failure |
3.8% |
| Thrombocytopenic Purpura |
3.8% |
| Urinary Tract Infection |
3.8% |
| Acute Generalised Exanthematous Pustulosis |
3.0% |
| Infection |
3.0% |
| Myocardial Infarction |
3.0% |
| Pulmonary Embolism |
3.0% |
| Sepsis |
3.0% |
| Syncope |
3.0% |
| Tachycardia |
3.0% |
| White Blood Cell Count Decreased |
3.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
30.6% |
| Multiple Myeloma |
9.7% |
| Non-small Cell Lung Cancer |
8.0% |
| Prophylaxis |
6.5% |
| Nausea |
4.9% |
| Vomiting |
3.7% |
| Pain |
3.6% |
| Dyspepsia |
3.5% |
| Breast Cancer |
3.4% |
| Glioblastoma Multiforme |
2.9% |
| Ovarian Cancer |
2.7% |
| Prophylactic Chemotherapy |
2.7% |
| General Anaesthesia |
2.5% |
| Prophylaxis Of Nausea And Vomiting |
2.5% |
| Arthralgia |
2.5% |
| Hypertension |
2.4% |
| Premedication |
2.2% |
| Prostate Cancer |
2.1% |
| Osteoporosis |
2.0% |
| Colorectal Cancer |
1.6% |
|
| Vomiting |
15.1% |
| Thrombocytopenia |
13.9% |
| Pyrexia |
7.6% |
| White Blood Cell Count Decreased |
7.3% |
| Sepsis |
7.1% |
| Pulmonary Embolism |
5.3% |
| Weight Decreased |
4.8% |
| Vision Blurred |
4.0% |
| Pneumonia |
3.5% |
| Neutropenia |
3.3% |
| Sinus Tachycardia |
3.3% |
| Rash |
3.0% |
| Syncope Vasovagal |
3.0% |
| Tooth Extraction |
3.0% |
| Renal Failure Acute |
2.8% |
| Septic Shock |
2.8% |
| Tremor |
2.8% |
| White Blood Cell Count Increased |
2.8% |
| Platelet Count Decreased |
2.5% |
| Osteonecrosis |
2.3% |
|
| Interacting |
| General Anaesthesia |
35.2% |
| Drug Use For Unknown Indication |
20.4% |
| Osteotomy |
16.7% |
| Anaesthesia |
11.1% |
| Musculoskeletal Pain |
11.1% |
| Neuralgia |
5.6% |
|
| Myotonia |
80.0% |
| Anaphylactoid Shock |
10.0% |
| Urinary Incontinence |
10.0% |
|
